- NCPA urges Medicare to extend DMEPOS accreditation deadline
- Walgreens puts its money where its mouth is with World AIDS Day campaign
- Adherence is boosted by face-to-face contact, study finds
- U.S. healthcare system should look to VA as baby boomers turn to Medicare
- Walgreens launches high-impact push in support of World AIDS Day campaign
ALEXANDRIA, Va. — The National Association of Chain Drug Stores announced on Wednesday that it has submitted comments to the U.S. House Ways and Means Subcommittee on Health urging that retail pharmacies remain exempt from the Medicare durable medical equipment competitive bidding program. The subcommittee held a hearing regarding the program on Wednesday.
“Without this exclusion, it is highly unlikely that retail pharmacies would be able to furnish DTS [diabetes testing supplies] in Medicare, since competitive bidding reimbursement rates are below DTS product costs for retail pharmacies. Limiting access to DTS will lead to poorer health outcomes and escalating costs of care,” NACDS stated in its comments. “This reimbursement reduction would hurt access to care and severely limit the valuable role of pharmacist-patient interactions in reducing overall program spending. Such reduced access and the elimination of face-to-face pharmacist counseling will lead to under-testing, decreased medication adherence, poorer outcomes, and increased overall costs.”
NACDS also urged alternative cost-savings approaches for the Medicare program, including moving diabetic testing supplies from Part B to Part D. Currently, prescription drugs related to diabetes, such as insulin, are provided to Medicare beneficiaries through Part D. However, durable medical equipment, such as diabetes monitors, testing strips and lancets, are provided to Medicare beneficiaries through Part B.
“Diabetes supplies should be covered through the Part D benefit. This would mirror commercial practices, would allow beneficiaries with diabetes to access necessary medications and supplies from the same provider if they chose, and would reduce costs by moving products to the more efficient Part D program,” NACDS stated in its comments.
NACDS also noted in its comments that chain pharmacies make up 66% of retail community pharmacies and are a “vital access point” for both diabetes testing supplies and prescription medications.
“Pharmacists are uniquely qualified as medication experts to work with patients needing medical supplies, such as diabetes testing supplies. Pharmacists play a key role in ensuring patients use their supplies in the most proper and meaningful way,” NACDS said.
In related news, the National Community Pharmacists Association announced it has endorsed the Medicare Access to Diabetes Supplies Act (H.R. 1936), which was introduced by Reps. Aaron Schock, R-Ill., and Peter Welch, D-Vt. The legislation would allow seniors to continue receiving essential diabetes testing supplies and expert counseling on their proper use, from independent community pharmacies, NCPA said.
"This bipartisan bill would help ensure that seniors can continue to rely on their independent community pharmacy for these essential diabetes supplies and the expert counseling needed to effectively manage their condition," NCPA CEO Douglas Hoey said. "At the same time, this proposal will reduce Medicare costs because it improves health outcomes."